{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:47:11Z","timestamp":1785847631712,"version":"3.56.0"},"reference-count":31,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"unspecified","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"General Guidance Project of Hospital Management Innovation Research of Jiangsu Provincial Hospital Association","award":["JSYGY-3-2023-103"],"award-info":[{"award-number":["JSYGY-3-2023-103"]}]},{"name":"General Guidance Project of Hospital Management Innovation Research of Jiangsu Provincial Hospital Association","award":["JSYGY-3-2023-114"],"award-info":[{"award-number":["JSYGY-3-2023-114"]}]},{"name":"Key Project of Infection Management of Suzhou Hospital Association","award":["SZSYYXH-2023-ZD1"],"award-info":[{"award-number":["SZSYYXH-2023-ZD1"]}]},{"name":"Key Project of Hospital Management Innovation Research of Jiangsu Provincial Hospital Association","award":["JSYGY-2-2024-256"],"award-info":[{"award-number":["JSYGY-2-2024-256"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2026,7,16]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the differences in pathogenic bacterial profiles between ventilator-associated pneumonia (VAP) and non-ventilator-associated hospital-acquired pneumonia (NV-HAP) and to provide data to support clinical infection prevention and control.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>A retrospective observational study using surveillance data, accompanied by a statistical analysis of pathogen-related variables between the two study cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Sixty-one secondary and tertiary healthcare institutions in a single city. Data were extracted from the city\u2019s regional healthcare-associated infection surveillance platforms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Inpatients (\u226518 years old) diagnosed with confirmed hospital-acquired pneumonia (HAP), including VAP and NV-HAP, at the aforementioned 61 healthcare institutions during the study period. Patients with community-acquired pneumonia (CAP) were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>(1) Pathogen distribution in patients with VAP and NV-HAP; (2) temporal trends in pathogen isolation rates (January 2020\u2013December 2024) in both groups; (3) antimicrobial resistance<\/jats:p>\n                    <jats:p>\n                      characteristics of major pathogens, including detection\/composition ratios of key multidrug-resistant organisms (MDROs): carbapenem-resistant\n                      <jats:italic>Acinetobacter baumannii<\/jats:italic>\n                      (CRAB), methicillin-resistant\n                      <jats:italic>Staphylococcus aureus<\/jats:italic>\n                      (MRSA), carbapenem-resistant\n                      <jats:italic>Escherichia coli<\/jats:italic>\n                      (CREC), carbapenem-resistant\n                      <jats:italic>Klebsiella pneumoniae<\/jats:italic>\n                      (CRKP) and carbapenem-resistant\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      (CRPA); (4) susceptibility of major pathogens to antimicrobials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Pathogen distribution differed between the two groups, with Gram-negative bacteria being predominant in both groups (73.72% vs 80.98%). Among patients with NV-HAP, the isolation rates of\n                      <jats:italic>K.\u202fpneumoniae<\/jats:italic>\n                      ,\n                      <jats:italic>Burkholderia cepacia<\/jats:italic>\n                      and\n                      <jats:italic>Candida albicans<\/jats:italic>\n                      showed a decreasing trend, whereas\n                      <jats:italic>A.\u202fbaumannii<\/jats:italic>\n                      exhibited a slow increase. In patients with VAP, the isolation rates of\n                      <jats:italic>K.\u202fpneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>B.\u202fcepacia<\/jats:italic>\n                      decreased, whereas\n                      <jats:italic>Stenotrophomonas maltophilia<\/jats:italic>\n                      increased. The proportion of drug-resistant bacteria was higher in patients with VAP than in those with NV-HAP (28.12% vs 19.74%). CRAB showed higher detection and composition ratios in the former group (77.37% and 48.05%, respectively). The MRSA detection rates were approximately 50% in both groups, whereas the CREC detection rate was below 6%. CRPA detection increased in patients with VAP, whereas CRKP and CRPA detection rates decreased in patients with NV-HAP. The antimicrobial resistance profiles of major pathogens were similar between the two groups.\n                      <jats:italic>K.\u202fpneumoniae<\/jats:italic>\n                      and\n                      <jats:italic>E.\u202fcoli<\/jats:italic>\n                      remained susceptible to most antimicrobials, whereas CRKP and CREC were susceptible to only a few agents, such as tigecycline and polymyxin B.\n                      <jats:italic>A.\u202fbaumannii<\/jats:italic>\n                      exhibited high resistance rates, with both\n                      <jats:italic>A.\u202fbaumannii<\/jats:italic>\n                      and CRAB being susceptible only to tigecycline, minocycline and polymyxin B.\n                      <jats:italic>P.\u202faeruginosa<\/jats:italic>\n                      and CRPA were largely susceptible to most antimicrobials.\n                      <jats:italic>S.\u202fmaltophilia<\/jats:italic>\n                      exhibited a ceftazidime resistance rate exceeding 36%, and\n                      <jats:italic>B.\u202fcepacia<\/jats:italic>\n                      exhibited ticarcillin\/clavulanate and cefoperazone\/sulbactam resistance rates exceeding 67%. The resistance rates of\n                      <jats:italic>S.\u202faureus<\/jats:italic>\n                      and MRSA to penicillin, erythromycin and clindamycin ranged from 41.83% to 98.72%. The resistance rates of\n                      <jats:italic>C.\u202falbicans<\/jats:italic>\n                      to commonly used antifungal agents were below 8%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The two groups differed in the distribution and antimicrobial resistance of the pathogens and MDROs, and these profiles fluctuated over time. Patients with VAP have a higher percentage of drug-resistant bacteria, requiring special attention to CRAB and CRPA. Local microbiological epidemiological surveillance should be strengthened to improve infection prevention, control strategies and guide empirical antibiotic therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2026-116593","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:56:28Z","timestamp":1785844588000},"page":"e116593","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Differences and trends in pathogens between ventilator-associated pneumonia and non-ventilator-associated pneumonia: data from 61 hospitals in Suzhou, China, 2020\u20132024"],"prefix":"10.1136","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3869-4653","authenticated-orcid":false,"given":"Jiajia","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Infection Management, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Infection Management, The First Affiliated Hospital of Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Infection Management, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinling","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Infection Management, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Gusu School, Nanjing Medical University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Infection Management, The First Affiliated Hospital of Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"2026080404551982000_16.8.e116593.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-023-07210-9"},{"key":"2026080404551982000_16.8.e116593.2","first-page":"1246","article-title":"Cross-sectional survey report on nosocomial infections in 186 medical institutions in Guizhou Province in 2022 [J]","volume":"22","author":"Yanyan","year":"2023","journal-title":"Chinese Journal of Infection Control"},{"key":"2026080404551982000_16.8.e116593.3","first-page":"452","article-title":"Cross-sectional survey and analysis of nosocomial infections in 203 medical institutions in Yunnan Province [J]","volume":"39","author":"Lei","year":"2022","journal-title":"Chinese Journal of Disinfection"},{"key":"2026080404551982000_16.8.e116593.4","first-page":"255","article-title":"Guidelines for the Diagnosis and Treatment of Hospital-acquired Pneumonia and Ventilator-associated Pneumonia in Adults (2018 Edition) [J]","volume":"41","year":"2018","journal-title":"Chinese Journal of Tuberculosis and Respiratory Diseases"},{"key":"2026080404551982000_16.8.e116593.5","first-page":"969","article-title":"Epidemiological Characteristics and Risk Factors Analysis of Non-ventilator-Associated Hospital-acquired Pneumonia in Elderly Patients in a Certain Hospital in Shanghai [J]","volume":"29","author":"Yuehuo","year":"2023","journal-title":"Geriatrics and Health Care"},{"key":"2026080404551982000_16.8.e116593.6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.14185","article-title":"Incidence and Outcomes of Non-Ventilator-Associated Hospital-Acquired Pneumonia in 284 US Hospitals Using Electronic Surveillance Criteria","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2026080404551982000_16.8.e116593.7","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1097\/MS9.0000000000000836","article-title":"Ventilator associated pneumonia in intensive care unit patients: a systematic review","volume":"85","author":"Mumtaz","year":"2023","journal-title":"Annals of Medicine & Surgery"},{"key":"2026080404551982000_16.8.e116593.8","first-page":"96","article-title":"Similarities and Differences in Hospital-Acquired Pneumonia\/Ventilator-Associated Pneumonia Guidelines in China, the United States, and Europe [J]","volume":"44","author":"Huachang","year":"2023","journal-title":"International Journal of Antibiotics"},{"key":"2026080404551982000_16.8.e116593.9","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics10070851","article-title":"Lower Respiratory Tract Pathogens and Their Antimicrobial Susceptibility Pattern: A 5-Year Study","volume":"10","author":"Santella","year":"2021","journal-title":"Antibiotics (Basel)"},{"key":"2026080404551982000_16.8.e116593.10","article-title":"Prevalence, outcomes, and predictors of multidrug-resistant nosocomial lower respiratory tract infections among patients in an ICU","volume":"49","author":"Beatriz Souza de Oliveira1","year":"2023","journal-title":"J Bras Pneumol"},{"key":"2026080404551982000_16.8.e116593.11","first-page":"61","article-title":"Diagnostic Criteria for Hospital Infections (Trial Version) [J]","volume":"81","year":"2001","journal-title":"Chin Med J"},{"key":"2026080404551982000_16.8.e116593.12","unstructured":"The National Health Commission of the People's Republic of China . In: Collection and Transportation of Clinical Microbiological Examination Specimens: WS\/T 640-2018 [S]. Beijing: China Standards Press, 2018."},{"key":"2026080404551982000_16.8.e116593.13","unstructured":"Clinical and Laboratory Standards Institute . Performance Standards for Antimicrobial Susceptibility Testing[S]. M100-S32. Wayne, PA: Clinical and Laboratory Standards Institute, 2022."},{"key":"2026080404551982000_16.8.e116593.14","first-page":"689","article-title":"The Correlation between Pathogenic Bacteria and Imaging Features of Hospital-acquired Pneumonia and Ventilator-associated Pneumonia [J]","volume":"47","author":"Xin","year":"2024","journal-title":"Journal of Molecular Imaging"},{"key":"2026080404551982000_16.8.e116593.15","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2021.36.e251","article-title":"The Distribution of Multidrug-resistant Microorganisms and Treatment Status of Hospital-acquired Pneumonia\/Ventilator-associated Pneumonia in Adult Intensive Care Units: a Prospective Cohort Observational Study","volume":"36","author":"Chang","year":"2021","journal-title":"J Korean Med Sci"},{"key":"2026080404551982000_16.8.e116593.16","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40121-023-00820-2","article-title":"Antimicrobial Resistance in Ventilator-Associated Pneumonia: Predictive Microbiology and Evidence-Based Therapy","volume":"12","author":"Alnimr","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2026080404551982000_16.8.e116593.17","first-page":"944","article-title":"Analysis of the composition and drug sensitivity of isolated bacteria in bronchoalveolar lavage fluid in Shandong region from 2017 to 2022 [J]","volume":"49","author":"Li","year":"2024","journal-title":"Chinese Journal of Antibiotics"},{"key":"2026080404551982000_16.8.e116593.18","doi-asserted-by":"crossref","first-page":"102995","DOI":"10.1016\/j.ebiom.2020.102995","article-title":"Reconsidering ventilator-associated pneumonia from a new dimension of the lung microbiome","volume":"60","author":"Fern\u00e1ndez-Barat","year":"2020","journal-title":"EBioMedicine"},{"key":"2026080404551982000_16.8.e116593.19","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1109418","article-title":"Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development","volume":"13","author":"Liao","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"2026080404551982000_16.8.e116593.20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jointm.2023.11.007","article-title":"Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units","volume":"4","author":"Kuloglu","year":"2024","journal-title":"Journal of Intensive Medicine"},{"key":"2026080404551982000_16.8.e116593.21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00812-X"},{"key":"2026080404551982000_16.8.e116593.22","first-page":"2075","article-title":"Technical Guidelines for Prevention and Control of Carbapenem-Resistant Gram-Negative Bacteria (CRON) Infections in China [J]","volume":"29","author":"Bijie","year":"2019","journal-title":"Chinese Journal of Hospital Infection"},{"key":"2026080404551982000_16.8.e116593.23","first-page":"45","article-title":"Distribution characteristics and drug resistance analysis of multi-drug resistant bacteria in hospital-acquired pneumonia and ventilator-associated pneumonia from 2019 to 2021 [J]","volume":"21","author":"Xia","year":"2023","journal-title":"Clinical Drug Therapy Journal"},{"key":"2026080404551982000_16.8.e116593.24","first-page":"627","article-title":"2023 CHINET China Bacterial Resistance Monitoring [J]","volume":"24","author":"Yan","year":"2024","journal-title":"Chinese Journal of Infection and Chemotherapy"},{"key":"2026080404551982000_16.8.e116593.25","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-019-1080-y","article-title":"Clinical epidemiology and outcomes of ventilator-associated pneumonia in critically ill adult patients: protocol for a large-scale systematic review and planned meta-analysis","volume":"8","author":"Guti\u00e9rrez","year":"2019","journal-title":"Syst Rev"},{"key":"2026080404551982000_16.8.e116593.26","doi-asserted-by":"crossref","first-page":"107120","DOI":"10.1016\/j.ijantimicag.2024.107120","article-title":"International guidelines for the treatment of carbapenem-resistant Gram-negative Bacilli infections: A comparison and evaluation","volume":"63","author":"Wang","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"2026080404551982000_16.8.e116593.27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-0041-1740583","article-title":"Methicillin-Resistant Staphylococcus aureus Hospital-Acquired Pneumonia\/Ventilator-Associated Pneumonia","volume":"43","author":"Pickens","year":"2022","journal-title":"Semin Respir Crit Care Med"},{"key":"2026080404551982000_16.8.e116593.28","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.129080.1","article-title":"Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19","volume":"12","author":"Hammoudi Halat","year":"2023","journal-title":"F1000Res"},{"key":"2026080404551982000_16.8.e116593.29","doi-asserted-by":"crossref","unstructured":"Tamma PD , Heil EL , Justo JA , et al . Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis 2024.:ciae403. doi:10.1093\/cid\/ciae403","DOI":"10.1093\/cid\/ciae403"},{"key":"2026080404551982000_16.8.e116593.30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","article-title":"Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli","volume":"56","author":"Zeng","year":"2023","journal-title":"J Microbiol Immunol Infect"},{"key":"2026080404551982000_16.8.e116593.31","first-page":"652","article-title":"COVID-19: dealing with ventilator shortage","volume":"28","author":"Santini","year":"2022","journal-title":"Curr Opin Crit Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2026-116593","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:56:41Z","timestamp":1785844601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2026-116593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,4]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bmjopen-2026-116593"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2026-116593","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}